FDA-Approved Pharmacotherapy for Weight Loss Over the Last Decade-Reference-Cited by-同舟云学术

FDA-Approved Pharmacotherapy for Weight Loss Over the Last Decade

Published:2022-09-17 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Idrees Zarwa,Cancarevic Ivan,Huang Li

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference33 articles.

1. A discourse on the nature, causes, and cure of corpulency. Illustrated by a remarkable case, read before the Royal Society, November 1757;Flemyng M,1757

2. Obesity: definition, comorbidities, causes, and burden;Apovian CM;Am J Manag Care,2016

3. Humans against obesity: who will win?;Caballero B;Adv Nutr,2019

4. World Health Organization. Noncommunicable diseases. (2017). Accessed: 22 June, 2022: http://www.who.int/mediacentre/factsheets/fs355/en/.

5. Obesity as disruptor of the female fertility;Silvestris E;Reprod Biol Endocrinol,2018

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Different Doses and Forms of the GLP-1 Receptor Agonist Semaglutide in Weight Reduction Among Non-diabetic Obese or Overweight Populations;Cureus;2024-09-06

2. Bridging the Gap: A Literature Review of Advancements in Obesity and Diabetes Mellitus Management;Applied Sciences;2024-07-27

3. A New Drug for Obesity: Tirzepatide;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-07-11

4. The effect of obesity pharmacotherapy on body composition, including muscle mass;International Journal of Obesity;2024-05-14

5. Body Composition in Anti-Obesity Medication Trials—Beyond Scales;JAMA Internal Medicine;2024-04-01